Abstract

There is provided an ex-vivo insect screening model to accurately determine blood-brain barrier penetration of different nanoparticles in order to improve the compound screening procedures/processes in the early drug discovery process. This object offers many advantages relative to prior technologies since insect models are more reliable tools for the decision-making process than the existing in vitro models, and will speed up the drug screening process and reduce the late phase attrition rate. Moreover, it will reduce the number of mammals sacrificed during the drug discovery phase.


Claims
Download PDF
Document Preview
Document History
  • Publication: May 3, 2012
  • Application: Sep 30, 2011
    WO DK 2011050367 W
  • Priority: Oct 25, 2010
    DK DK PA201000969 A

Download Citation


Sign in to the Lens

Feedback